PROFESSIONAL EDITION

The largest community of pharma leaders

Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you need to know about our work and the resources available for you. You need to confirm your subscription by email (check your email box and confirm your subscription)

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

4. All our newsletters needs to be confirmed by email. After you subscribe on our webpage, you will receive an email asking for your confirmation by clicking a link. Click that link if you want to receive the newsletter. If you don’t receive the email, check your spam box and add our email to your safe sender list. If you address belongs to a company, you may need to forward your confirmation email to your tech department to ask them to add our domain to your company safe sender list. 

You can start here by subscribing to our main Newsletter. Confirm your subscription by clicking CONFIRM on the email you will receive after complete the subscription form.

Don’t forget to check for our other newsletters! Check this page for several options we have for all our users!

NEWSLETTER ANNOUCEMENTS




TPMG FEATURED WRITER NEWSLETTER




2020: looking back at the year when everything changed

A version of this article was previously published on Pharmaphorum. I think it’s fair to say that 2020 will not...

Top 10 Tips for Creating Company Culture in a...

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may...

Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Natalie Yeadon´s Newsletter




2020: looking back at the year when everything changed

A version of this article was previously published on Pharmaphorum. I think it’s fair to say that 2020 will not...

Top 10 Tips for Creating Company Culture in a...

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may...

Top 10 Reasons Why Virtual Collaboration and Medical Education...

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left...

Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Tommaso Salanitri´s Newsletter




“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

EDITOR´S PICK




Pfizer and BioNTech Initiate a Study as Part of...

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today they have begun...

Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical...

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Click Therapeutics, Inc. announce the initiation...

Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351,...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces that it...

Moderna Announces Additional Capital Investments to Increase Global Manufacturing...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces it is...

SIRION Biotech Announces Collaboration with Sanofi to Innovate Gene...

MUNICH--(BUSINESS WIRE)--SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced...

Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused...

LOOK WHO IS ON THE MOVE!




Median Strengthens its iBiopsy® Leadership Team With the Appointment...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today the appointment of Thomas Bonnefont to the newly created...

Ipsen Receives Positive CHMP Opinion Recommending Cabometyx® in Combination...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP)...

Talaris Therapeutics Appoints Four Vice Presidents in Areas of...

BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing an innovative method of allogeneic...

Monte Rosa Therapeutics Strengthens Leadership with Key Executive and...

BOSTON--(BUSINESS WIRE)--Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing proteins, announced...

Gary Fishbein, MD, MPH, Joins Worldwide Clinical Trials as...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO),...

ImmunityBio Appoints John Brennan and Wesley Clark to Board...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc., a privately-held immunotherapy company, today announced the appointment of John Brennan, former Central Intelligence...

INDUSTRY NEWS




Roivant Grows Computational Drug Discovery Engine with Acquisition of...

NEW YORK & BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Roivant Sciences today announced it has entered into a definitive agreement to...

BeiGene Announces Closing of Collaboration with Novartis to Develop...

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing...

SYLVANT® (siltuximab) Recommended by the National Comprehensive Cancer Network®...

HEMEL HEMPSTEAD, England & BURLINGTON, Mass.--(BUSINESS WIRE)--EUSA Pharma (UK) Limited (“EUSA Pharma”), a global biopharmaceutical company focused on oncology...

Charles River Laboratories Announces Strategic Partnership with Kibur Medical...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic partnership with Kibur Medical to offer...

Merck Animal Health Completes Acquisition of Poultry Sense Limited

MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of...

Takeda to Divest Four Diabetes Products in Japan to...

OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to...

REGULATORY AFFAIRS




Incyte Announces the Validation by the European Medicines Agency...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced the validation of the Company’s Marketing Authorization Application (MAA) for retifanlimab, an intravenous...

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo®...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP)...

Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX®...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today announced that its partner Ipsen received a positive opinion from the Committee...

EMA Accepts Marketing Application for Somatrogon to Treat Pediatric...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European...

European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization...

Locate Bio’s Chondro3 Granted FDA Breakthrough Device Designation

NOTTINGHAM, England--(BUSINESS WIRE)--Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and...

MEDICAL DEVICES




EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that...

New Alcon Innovations in Intraocular Lenses, Digital Health Solutions...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, will highlight a...

Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development...

BOSTON & LONDON--(BUSINESS WIRE)--Synthace Ltd and Ipsen, a global biopharmaceutical company focused on innovation and specialty care, have partnered...

World’s Leading Home Improvement Retailer Battling COVID-19 Impact with...

MIDDLETOWN, Conn.--(BUSINESS WIRE)--Reality Interactive, a leading retail technology design firm and digital agency in Middletown, Connecticut, announced the launch...

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency...

Optomec Delivers 3D Electronics Printer for Medical Device Production

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Optomec has delivered a new industrialized 3D Printed Electronics system to a major US healthcare manufacturer, where...

HOSPITAL NEWS




Altasciences Performs Phase I Studies for FDA Approval of...

LAVAL, Quebec--(BUSINESS WIRE)--Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early...

Abzena Selected by Immunome to Develop and Manufacture Antibody...

EXTON, Pa. & SAN DIEGO--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell...

Bristol Myers Squibb and The Rockefeller University Announce License...

NEW YORK--(BUSINESS WIRE)--BMS & The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment...

PhysIQ Saw Significant Adoption of Their AI Technology in...

CHICAGO--(BUSINESS WIRE)--PhysIQ, Inc. will mark 2020 as a very important year-to-date for the leader in furthering acceptance and adoption...

EUSA Pharma and BeiGene Announce Acceptance of a Biologics...

January 25, 2021 07:00 AM Eastern Standard Time HEMEL HEMPSTEAD, England & BEIJING, China & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EUSA Pharma (UK)...

Turnstone Biologics Acquires Novel Cell Therapy Platform

NEW YORK--(BUSINESS WIRE)--Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio...

CLINICAL TRIALS




BioAge Initiates Phase 2a Trial of BGE-117 in Elderly...

RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, today...

Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal...

MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed...

Revance Announces Positive Topline Phase 2 Data Supporting Advancement...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced...

Ipsen Announces New Data from the Phase II CLARINET...

PARIS--(BUSINESS WIRE)--Ipsen (Euronext: IPN; ADR: IPSEY) announced today a total of 9 abstracts presenting new data with a focus...

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s...

POTOMAC, Md.--(BUSINESS WIRE)--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) is pleased to announce the progress...

Avacta Announces Phase 1 Clinical Trial Authorisation (CTA) for...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it...